NEW YORK (GenomeWeb News) – German microarray services firm imagines said today that it has been named an Agilent Technologies Certified Services Provider for expression profiling services.
 
The Berlin-based firm said that the CSP status involves the application of the entire Agilent microarray workflow, from quality controls to reagents, data extraction, and analysis software with the Genespring DX platform.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.